Vanguard Group Inc Covetrus, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.69 - $20.91 $4.67 Million - $4.72 Million	225,531 Added 1.93%	11,883,153 $248 Million
Q2 2022 Aug 12, 2022	BUY	$13.8 - $20.82 $1.49 Million - $2.25 Million	108,160 Added 0.94%	11,657,622 $242 Million
Q1 2022 May 13, 2022	BUY	$15.96 - $18.87 $5.15 Million - $6.09 Million	322,572 Added 2.87%	11,549,462 $194 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $20.37 $5.24 Million - $6.36 Million	312,198 Added 2.86%	11,226,890 $224 Million
Q3 2021 Nov 12, 2021	BUY	$18.14 - $27.03 $50,284 - $74,927	2,772 Added 0.03%	10,914,692 $198 Million
Q2 2021 Aug 13, 2021	BUY	$25.24 - $30.86 $275 Million - $337 Million	10,911,920 New	10,911,920 $295 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.